- Select a blog category
Over the past few weeks the realities of the financial challenges facing the NHS have become increasingly evident. Analysis by the Nuffield Trust estimates that hospitals will have to achieve twice the level of efficiencies achieved in recent years, to have any hope of closing the £22 billion funding gap by 2020. Furthermore, that without extra funding or unprecedented savings and a steep reduction in patient demand, major cuts in services are inevitable. Evidence is already emerging that treatment waiting times are increasing and rationing is becoming more pervasive.i This week’s blog considers one example of this rationing, cataract surgery, the leading case of reversible blindness and visual impairment worldwide. This issue resonates personally with me, as I saw first-hand the distressing impact that this condition can have on a loved one.
In our recent report Vital Signs: How to deliver better healthcare across Europe, one of the vital signs was hospital productivity which highlighted the importance of standardised systems and processes, technology and new ways of working. This week’s blog discusses how one hospital group in the United States (US) standardised its clinical processes across multiple sites to improve efficiency and productivity. This is the second in a series of contributions from Dr Bob, a partner in our health consulting business on secondment from the US who has spent 20 years as a practicing physician in the US, followed by 20 years as a healthcare consultant working with numerous health systems.
This week we’re delighted to feature an article written by our US colleague Terri Cooper, PhD, Principal and the Federal Health Sector Leader, Deloitte Consulting, LLP on a subject that is personal to us all. Most of us will know of someone, a friend, colleague or family member that cancer has impacted. While the Cancer Moonshot is a US led initiative, the outcomes should, in time, benefit us all in our fight against cancer.
The NHS may have survived financial scrutiny in 2015-16 but how sustainable is the current funding model?
The financial challenges facing the NHS have been a keen focus of policy and media commentators for much of 2015-16. However, until last week, a key question on many people’s minds was whether the Department of Health (Department) and the NHS would exceed their 2015 -16 agreed expenditure limits and, if so, the impact of this on 2016-17 spending. In the event, the publication of the National Audit Office (NAO) reports on the audited accounts of the Department, NHS England and NHS Foundation Trusts’ consolidated accounts 2015-16, provides the definitive view.i This week’s blog explores the key findings from the NAO’s scrutiny of NHS spending in 2015-16 and the implications for the future sustainability of the NHS in the face of continuing increases in demand and constrained funding.
Last week we published our report ‘Vital Signs: How to deliver better healthcare across Europe’, which focussed predominantly on what good care might look like. The report highlights three common enablers across all seven vital signs intended to help transform healthcare services: standardising systems and processes, workforce working differently and the adoption of health technology. This week’s blog provides deeper insight into the Partnership Vital Sign, with a focus on the benefits that can be derived from building successful digital partnerships between life sciences and technology companies. This blog, authored by Roland Foxcroft one of our Monitor Deloitte colleagues, appeared in Scripi and is the first in a series of exclusive columns that Deloitte is providing to Scrip, and which we agreed we would subsequently share with our readers.
Health systems in Europe are diverse, the result of history, culture and the economic and political environment in which they operate. They range from predominantly single-payer systems, such as the UK and Spain, which tend to spend a lower amount of their resources (Gross Domestic Product (GDP)) on healthcare; to systems of competing insurers and providers such as Germany and the Netherlands, which are two of Europe’s highest spenders on healthcare. Understanding what makes an effective healthcare system is therefore quite challenging. This week’s blog summarises the findings in our new report, Vital Signs- How to deliver better healthcare across Europe.
Digital technology is helping to transform the way citizens interact with service providers across all service industries. The time is now ripe for changing the relationship between health and social care commissioners and providers and service users. This week’s Thought from the Centre blog brings you the views of our lead partner for social services on the need for an increased focus on digital transformation across health and social care through the adoption of a more ‘digital mindset’.
Keep calm and carry on: How can the healthcare and life sciences industries weather the Brexit storm?
We have now had the best part of a week to absorb the momentous news that the UK has voted to leave the European Union. Much has been written about this seismic event and, following our blog in February this year, on what Brexit might mean for the healthcare and life sciences industries,i we thought we should use this week’s blog to update our views on the potential risks and opportunities for our life sciences and healthcare sectors.
This week’s blog is by one of the directors in our health consulting business, who is currently on secondment to Australia, building her knowledge and experience of other health care systems and hoping to take the best practice from the UK to support Australia to deliver sustainable, high quality health services, and to bring their good ideas back here.
In 2014 we published a report on End of Life Care in the UK and subsequently have written a number of related blogs on this important subject. This week’s blog has been written by a member of our team, based in India, who was motivated to write it having helped us with our research for our upcoming report on ‘Vital Signs: How to deliver better healthcare across Europe - which includes palliative and end of life care as one of the seven vital signs and highlights its importance as a quality measure healthcare system performance.
This week’s blog is by one of our partners in our health consulting business on a two-year secondment to the UK from the US. Dr Robert Williams (Dr Bob to all who know him) is helping us to leverage his knowledge and experience in our work with NHS organisations, particularly in relation to population health management and IT implementation. Over to Dr Bob!